Last reviewed · How we verify
NCT02528006
Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges
Phase 2, PHASE3 trial testing Type 2 Thyroplasty using Titanium Bridges in Adductor Spasmodic Dysphonia in 20 participants. Completed in 29 March 2017.
29 March 2017
Quick facts
| Lead sponsor | Kumamoto University |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 20 |
| Start date | 27 July 2015 |
| Primary completion | 29 March 2017 |
| Estimated completion | 29 March 2017 |
| Sites | 4 locations across Japan |
Drugs / interventions tested
- Type 2 Thyroplasty using Titanium Bridges
Conditions studied
- Adductor Spasmodic Dysphonia — all drugs for Adductor Spasmodic Dysphonia →
Sponsor
Kumamoto University
Who can join
Adults 18 to 80, any sex, with Adductor Spasmodic Dysphonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For adductor spasmodic dysphonia, there is a need for establishing a new therapy under the present circumstance where no standard therapy has been established yet and existing therapies fail to provide permanent effect. Evaluation of the efficacy of type 2 thyroplasty using titanium bridges will expand the therapeutic options available for adductor spasmodic dysphonia and establishment of a standard therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02528006
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Kumamoto University trials
Trials by the same sponsor.
- NCT03248232 — Assessments of Thrombus Formation in TAVI · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02528006 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kumamoto University
- Last refreshed: 2 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02528006.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing